Podcasts about rph

Peptides continue to gain popularity for their potential preventive and proactive health benefits. Yet as the buzz grows, so does the confusion. Emerging research touts their ability to treat injuries, optimize health, and rejuvenate the body; at the same time, questionable gray-market options and misinformation have become more prevalent.     In this episode, Jim LaValle, RPh, CCN, explores the evolution of the peptide revolution. He breaks down the key differences between research peptides and for-human-use peptides, explains how FDA oversight is shifting, and shares tips for spotting credible information, prioritizing safety, and making informed choices.   This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/the-evolving-peptide-revolution-performance-longevity-series   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.    Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

Read transcriptLIVE from ILADS: Tick Boot Camp sits down with David W. Kazarian, RPh, pharmacist and founder of Infuserve America, for a focused conversation recorded in person at the ILADS Annual Scientific Conference. In this short-form conference interview, Kazarian explores how compounding pharmacy can give practitioners additional options for Lyme disease and tick-borne illness patients dealing with medication sensitivities, reactions to fillers and excipients, alpha-gal syndrome, absorption challenges, and other complexities. With decades of experience working with the Lyme community, he explains why changing the formulation of a medication — not just the active ingredient — can sometimes become an important part of individualized care. This interview was recorded live on the conference floor, so you may hear some of the energy and background activity of ILADS throughout the conversation. What Is Compounding Pharmacy? Kazarian describes compounding as both a science and an art. Commercial medications generally come with predetermined doses, capsules, fillers, dyes, and delivery methods. Compounding gives a pharmacist, working with a prescribing practitioner, the ability to customize certain aspects of a medication for an individual patient's needs. Depending on the prescription and patient, that can include changes to: Medication strength or dosage Fillers and excipients Capsule materials Carrier oils Route of administration Release characteristics Topical or oral formulations Sterile or non-sterile preparations For people navigating complex Lyme disease and other tick-borne illnesses, those details may become particularly important when medication sensitivities develop or change over time. Excipients, Fillers & Medication Sensitivities One of the most important topics in this conversation is excipients — ingredients in a medication other than its primary active pharmaceutical ingredient. Kazarian discusses patients who may have difficulty tolerating ingredients such as dyes, magnesium stearate, titanium dioxide, gelatin capsules, certain carrier oils, animal-derived ingredients, and other fillers. For a highly sensitive patient, the question may therefore extend beyond "Can I tolerate this medication?" to "Can I tolerate this particular formulation of the medication?" A compounding pharmacist may be able to work with the prescribing practitioner to explore alternative formulations when appropriate. Alpha-Gal Syndrome & Animal-Derived Ingredients The conversation also explores alpha-gal syndrome, a tick-associated allergy that can make mammalian-derived ingredients problematic for some patients. Kazarian uses capsules as one example. Traditional gelatin capsules may contain animal-derived materials, while alternative formulations can use vegetable-based capsules. He also discusses carrier oils and other excipients, including MCT, almond, and olive oils, illustrating how even the inactive components of a medication may need to be considered for an individual patient. For people experiencing unexplained new sensitivities, the discussion provides an important takeaway: the active medication isn't necessarily the only ingredient worth investigating. Why Can Medication Tolerance Change? Many people living with Lyme disease and other complex chronic illnesses report becoming sensitive to foods, supplements, medications, or other substances they previously tolerated. Kazarian discusses immune dysfunction as one possible piece of this complicated picture and explains why changing medication tolerance deserves investigation. This is especially relevant for Lyme patients who experience symptoms that change, migrate, or seem disconnected from one another. Rather than automatically dismissing a new reaction because a medication was previously tolerated, the episode explores why practitioners may need to look more closely at both the patient's changing health and the medication's ingredients. Lyme Disease, Coinfections & Complex Illness Kazarian prefers looking broadly at tick-borne illness rather than focusing exclusively on Borrelia. The conversation discusses the polymicrobial nature of tick-borne disease, including coinfections and the potential involvement of immune and inflammatory processes. That complexity leads to one of the central themes of the interview: There isn't necessarily one recipe for every patient. Patients can present differently, tolerate treatments differently, and require different approaches as their health changes. Carrier Oils, Microemulsions & Medication Absorption Kazarian also explains the role of carrier oils and what he describes as microemulsions. Depending on the medication and formulation, these techniques may be used to influence delivery, absorption, or gastrointestinal tolerance. He describes the concept simply as surrounding a drug with fat and explains why understanding the chemistry of both the active medication and its delivery system can be an important part of pharmaceutical compounding. Thyroid Medication as an Example of Precision Medicine Kazarian uses thyroid medication to demonstrate how individualized investigation and compounding can work together. The discussion touches on TSH, T3 and T4, free T3 and free T4, reverse T3, iodine, ferritin, medication ingredients, animal-derived ingredients, bioidentical formulations, and sustained-release compounding. The thyroid discussion serves as a larger example of the questions that can arise with a complex patient: Is the medication itself the problem? Could an inactive ingredient be contributing? Is the formulation appropriate? Is something else in the patient's clinical picture being overlooked? These are questions for the patient's healthcare team to investigate rather than assuming there is a one-size-fits-all answer. Precision Medicine & the Pharmacist's Role A major theme throughout the interview is precision medicine. Kazarian describes the compounding pharmacist as another resource for the treating practitioner when conventional medication options create challenges. Depending on the individual situation, a pharmacist and prescribing clinician may consider a different formulation, excipient, dosage form, route of administration, release method, or active ingredient when clinically appropriate. Kazarian is also clear about something important: the pharmacist does not replace the patient's practitioner. Instead, the pharmacist can become another member of the team, helping the practitioner explore additional options when they encounter a medication-related obstacle. Sterile & Non-Sterile Compounding Infuserve America provides both sterile and non-sterile compounding. Non-sterile compounding can include customized capsules, tablets, topical preparations, and other formulations. Sterile compounding includes preparations requiring specialized sterile environments and procedures, including certain injectable and intravenous medications. With Infuserve America's background in home infusion, Kazarian also discusses prescribed IV therapies, PICC lines and ports, intravenous medications, nutritional IV preparations, Myers' cocktails, and high-dose vitamin C. Giving Practitioners More Tools Perhaps the most important message from Kazarian is that compounding isn't about replacing the doctor or allowing patients to prescribe for themselves. It's about giving practitioners more tools. Kazarian describes receiving calls from practitioners who have reached a difficult point with a patient and want to know what other options may be available. Could an excipient be changed? Could another route of administration work? Could the medication be prepared differently? Those conversations between practitioners and pharmacists can create possibilities that aren't available with an off-the-shelf medication. Patients interested in exploring compounding with their healthcare provider can learn more about working with Infuserve America. About David W. Kazarian, RPh David W. Kazarian, RPh is a registered pharmacist and founder of Infuserve America with decades of experience in pharmacy, home infusion, sterile and non-sterile compounding, and working with the Lyme disease community. His approach emphasizes collaboration between the pharmacist, practitioner, and patient to identify individualized solutions when conventional medication formulations present challenges. Key Topics in This Episode Lyme disease, tick-borne illness, compounding pharmacy, David Kazarian, Infuserve America, medication sensitivities, medication intolerance, excipients, fillers, alpha-gal syndrome, precision medicine, personalized medicine, immune dysfunction, carrier oils, microemulsions, thyroid medication, medication absorption, sterile compounding, home infusion, IV therapy, and practitioner-pharmacist collaboration. About This LIVE from ILADS Interview This short-form interview was recorded in person at the 2025 International Lyme and Associated Diseases Society (ILADS) Annual Scientific Conference, From Terrain to Treatment: Advances in Vector-Borne Illness, held October 9–12, 2025, in San Antonio, Texas. Tick Boot Camp was onsite interviewing doctors, researchers, healthcare professionals, advocates, and innovators working across Lyme disease and vector-borne illness. Explore all Tick Boot Camp LIVE from ILADS interviews to hear more conversations from the conference. More from Tick Boot Camp Hear more conversations with Lyme disease doctors and healthcare professionals about testing, treatment, complex chronic illness, and emerging approaches to tick-borne disease. Explore the Tick Boot Camp Podcast for interviews with patients, doctors, researchers, advocates, and other members of the Lyme disease and tick-borne illness community.

GLP-1s may be one of the most talked-about drug categories in recent years, but the story of its benefits goes well beyond weight loss.    In this episode, Jim LaValle, RPh, CCN, unpacks the reality of being on a GLP-1. From the emerging benefits to the risks that can derail results, he discusses how GLP-1s are changing the conversation around insulin resistance, heart disease, dementia risk, and more. He also emphasizes why a personalized approach and medical guidance are crucial for success and how to support your health along the way.   This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/the-reality-of-being-on-a-glp-1-performance-longevity-series/   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.

The Hidden Link Between Expensive Infusions and Rising Stop-Loss Renewal Premiums. Episode 530. When an infusion claim lands on a self-insured plan's high-cost claims report, it's tempting to treat the price tag as fixed — but the exact same infusion drug can cost 10 times more depending on where a member receives it, and every expensive claim that breaches a stop-loss attachment point can push next year's premium higher or get that member's claim lasered off coverage entirely. In this episode, Stacey Richter talks with Jake Velie, founder, chairman, and CEO of National Integrative Health (NIH), and Keith Hartman, RPh, NIH's chief strategy officer, about the direct — not dotted — line between overpaying for infusions and overpaying for stop-loss coverage, and the four pillars plan sponsors need to actually pull off site-of-care optimization. WHAT YOU'LL LEARN ✅ Why there's a direct, not dotted, line between expensive infusion claims and rising stop-loss renewal premiums — and how breaching an attachment point can get a claim lasered off coverage ✅ How the opacity of J-codes and Q-codes on the medical benefit hides how much margin is built into an infusion's billed cost, unlike the more visible pharmacy-benefit claims data ✅ Why the exact same infusion drug can cost 10 times more depending on where a member receives it ✅ The four pillars of a real site-of-care optimization program: deep clinical oversight, proactive pre-cert intervention, plan design and financial incentives, and member/influencer engagement ✅ Why a vague "denied" fax in the pre-cert process leaves prescribing clinicians in the dark and can sabotage a site-of-care redirect before it starts ✅ How home infusion can be used as a site-of-care option even when an anticompetitive hospital contract otherwise restricts steering WHY THIS MATTERS Stop-loss coverage is usually a self-insured plan's single biggest expense, yet Stacey Richter points out that the typical reaction to an expensive infusion claim is to treat it like an unalterable fate. The same infusion can cost 10 times more depending on where a member gets it, and every claim that breaches a stop-loss attachment point pushes premiums higher or risks getting the claim excluded from coverage. As medical and pharmacy trend keeps climbing, knowing how to steer members toward lower-cost, clinically appropriate sites of care is becoming a core skill for plan sponsors — not knowing how is turning into a problematic knowledge gap. MENTIONED IN THIS EPISODE EP529 with Eric Bricker, MD: Apple Podcasts | Spotify | Other Apps EP370 with Erik Davis and Autumn Yongchu: Apple Podcasts | Spotify | Other Apps EP468 with Matt McQuide: Apple Podcasts | Spotify | Other Apps Website: National Integrative Health EP501 with Ivana Krajcinovic, PhD: Apple Podcasts | Spotify | Other Apps EP508 with Lee Lewis: Apple Podcasts | Spotify | Other Apps EP480 with Kimberly Carleson: Apple Podcasts | Spotify | Other Apps EP523 with Suhas Gondi, MD, MBA: Apple Podcasts | Spotify | Other Apps EP472 with Eric Bricker, MD: Apple Podcasts | Spotify | Other Apps === LINKS ===

In 2005 Sara J White published a leadership survey in AJHP titled “Will there be a pharmacy leadership crises?”As a follow up to that study, David Chen, Bill Kernan, and I worked with ASHP's Section of Pharmacy Practice Leaders Executive Committee to update the national pharmacy leadership survey. The survey and results were published in a recent article in AJHP titled “Pharmacy Executive and Mid-Level Manager Perceptions of Leadership in Contemporary Health-System Pharmacy”. We talk through the origins of the survey, key results and what do as next steps with the information gathered. Dr. Bill Kernan, PharmD, MBA, FASHP, is the Director of Pharmacy at Orlando Health Watson Clinic Lakeland Highlands Hospital in Orlando, Florida. David Chen, RPh, MBA, is the Vice President for Pharmacy Leadership and Planning at ASHP.

If you've ever sat in a doctor's office, struggling with symptoms, only to be told your labs look perfectly fine, you're not alone. Who do you trust when your body tells you something is wrong, but on paper it says you're "within a normal range"?    In this episode, Jim LaValle, RPh, CCN, discusses the frustrating disconnect between feeling "off" and having "normal" lab results. In a traditional medical setting, "normal" often means you don't have a disease yet, which means it may be necessary to take a more comprehensive look to understand the direction your health is trending. It also means you can't ignore your symptoms.    LaValle shares the potential of a preventive approach to change your trajectory and the value of understanding your lab patterns over time.   This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA. Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/why-you-feel-off-but-your-labs-look-normal-performance-longevity-series/    Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.   Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

Specialty Pharmacy Access, Innovation & Independent Pharmacy Growth   This Week in Pharmacy, we explore specialty pharmacy, pharmacy innovation, emerging career opportunities, and new business models for independent community pharmacy.   Today's episode is sponsored by Clearway Health, Value Drug Company, and FDB (First Databank, Inc.)   First, Allison Arant of Clearway Health joins us to discuss the next phase of specialty pharmacy within hospitals and health systems.   As rare disease and specialty therapies become more complex, health systems are looking for better ways to improve medication access, strengthen continuity of care, and keep patients connected to trusted clinical teams.   Todd and Allison discuss how health-system specialty pharmacy can expand community access and improve management of complex and rare disease treatments.   Learn more: https://www.clearwayhealth.com/   National Association of Specialty Pharmacy (NASP) #inSPire2026   Next, we preview inSPire 2026, taking place September 22–25, 2026, at the Gaylord National Resort & Convention Center in National Harbor, Maryland.   The specialty pharmacy community will come together to discuss medication access, emerging therapies, technology, patient services, clinical care, and the continued evolution of specialty pharmacy.   The Next Dose Summit   Then we welcome Jordan Smith, PharmD, AAHIVP, CPGx, and Melinda Fowler, RPh, ABAAHP, FAAFM to preview The Next Dose Summit, happening October 14–15, 2026.   RxPR and the Pharmacy Podcast Network are proud press and media partners.   The event focuses on innovation, entrepreneurship, leadership, emerging career pathways, and new opportunities for pharmacists looking beyond traditional roles.   It is designed for pharmacists, students, entrepreneurs, and healthcare leaders asking one important question:   What's next for pharmacy — and what's next for me?   Register here: https://www.jscommunitycare.org/store/p/2026-the-next-dose-summit-registration   Expanding Independent Pharmacy   Finally, Rick Seipp, PharmD, President and CEO of Value Drug Company, returns to discuss creative strategies for expanding independent community pharmacy.   Todd and Rick explore cash-based pharmacy, transparent pricing, clinical services, new revenue streams, and other non-PBM-dependent models that can help independent pharmacies diversify and grow.   The conversation focuses on how community pharmacies can strengthen their businesses while continuing to serve as trusted healthcare destinations.   Learn more: https://www.valuedrugco.com/   Sponsored By   Clearway Health https://www.clearwayhealth.com/   Value Drug Company https://www.valuedrugco.com/   First Databank — FDB https://www.fdbhealth.com/   TWIRx — This Week in Pharmacy is hosted by Todd S. Eury and produced by the Pharmacy Podcast Network — Amplifying the Voice of Pharmacists & Our Profession.

There is a lot of conflicting information online about progesterone right now, particularly around whether women need to take it continuously, whether cycling is necessary, and whether progesterone can somehow interfere with estrogen or increase dementia risk. In this conversation, Dr. Phyllis Bronson, Carol Petersen, RPh, CNP, and Jill Chmielewski, RN, BSN, discuss some of the biggest claims circulating about progesterone and hormone therapy. The conversation explores the importance of progesterone, how different delivery methods can affect the way it works in the body, and why dose and individual response matter. They also discuss oral, topical and vaginal progesterone, the role of allopregnanolone, estriol and Bi-Est, and why measuring hormones in the blood doesn't always tell the full story of what is happening at the tissue level. They also tackle one of the biggest current controversies: the idea that continuous progesterone may increase dementia risk. The group discusses the evidence and theories behind this claim, the importance of balancing estradiol with progesterone, and why women need to be cautious about making hormone decisions based on simplified social media messaging. This is a wide-ranging conversation designed to give you more context, more questions to ask, and a deeper understanding of the ongoing debate around women's hormones. In this episode: The truth about continuous vs. cycling progesterone How progesterone works with estrogen in the body Oral, vaginal and transdermal progesterone: what's the difference? The controversy around progesterone and dementia risk Why hormone therapy needs to be individualized based on dose, delivery method and your unique response   About Phyllis Bronson, PhD Phyllis Bronson, Ph.D., holds a doctorate in biochemistry. Her ongoing research involves studying the biological impact of molecules on mood and emotion. Dr. Bronson works with women who have hormone-based mood disorders, utilizing her original research on human identical hormones. She lives in Aspen, Colorado, and is President of Biochemical Consulting and The Biochemical Research Foundation. Dr. Bronson is the author of Moods, Emotions, and Aging: Hormones and the Mind-Body Connection,and has authored many articles, which can be found here. In the Aspen area? On July 27th, the Jewish Community Center in Aspen will be hosting The Great Hormone Conversation with Phyllis and Dr. Alan Altman. For more info or tickets,click here.‍ ‍   About Carol Petersen, RPh, CNP Carol Petersen is an accomplished compounding pharmacist with decades of experience helping patients improve their quality of life through bioidentical hormone replacement therapy. She graduated from the University of Wisconsin School of Pharmacy and is a Certified Nutritional Practitioner. Her passion for optimizing health and commitment to compounding is evident in her involvement with organizations including the International College of Integrated Medicine and the American College of Apothecaries, the Academy of Anti-Aging Medicine (A4M), American Pharmacists Association and the Alliance for Pharmacy Compounding.  She was also the founder and first chair for the Compounding Special Interest Group with the American Pharmacists Association. She chairs the Integrated Medicine Consortium, an umbrella group for complementary medicine organizations.   She cohosts a radio program, "Take Charge of Your Health," in the greater New York area. She is on the Medical Advisory Boards for the Centre for Menstrual Cycle and Ovulation Research (CeMCOR.ca) and the Institute for Bioidentical Medicine (IOBIM.org). She also writes and edits for A4M's website www.worldhealth.net and is a co-producer of "Immortality Now" podcasts. Carol offers personal consultations at www.thewellnessbydesignproject.com. About Jill Chmielewski, RN, BSN Jill Chmielewski, a Registered Nurse, Certified Health Coach, Menopause Educator, and Women's Health Advocate with over 30 years of experience in healthcare. Most recently, Jill joined the Balance App team as the U.S. expert. Balance was founded by Dr. Louise Newson and is dedicated to educating and empowering women around the world with evidence-based information, helping them better understand their hormone health and make informed choices for their bodies.

Starting hormone replacement therapy can feel both exciting and overwhelming. What should you expect? How do you find the right provider? Which delivery method is best? And how long does it take before you actually start feeling better? In this episode of Perimenopause Simplified, Claudia Petrilli walks you through what the HRT journey can look like, from finding a hormone-savvy provider to understanding different delivery methods and the importance of starting low and going slow. Claudia discusses why simply finding someone who can prescribe HRT isn't always enough, what questions to ask when interviewing a provider, and why finding the right dose and combination of hormones can take some patience and fine-tuning. She also breaks down progesterone, estrogen, testosterone, DHEA, and several different delivery options, including patches, creams, pills, troches, injections, and pellets. Plus, she shares some of her own experiences with HRT, including the changes she noticed when starting testosterone and the difference estrogen made for her period-related body aches. If you're considering HRT or have already started and aren't sure what to expect, this episode will help you better understand the process and feel more prepared to advocate for yourself. In this episode, we covered: How to find an HRT provider Different deliveries of hormone replacement therapy Why hormone injections and pellets are not recommended Side effects of hormone replacement therapy Progesterone hormone replacement therapy Estrogen hormone replacement therapy Testosterone & DHEA hormone replacement therapy   Sources: Women's International Pharmacy Institute of Bioidentical Medicine (IOBIM)-trained providers The Academy for Preventive and Innovative Medicine (Worldlink Medical) Institute for Functional Medicine Carol Petersen, RPh, CNP Dr. Phyllis Bronson   _______________________________________________________________________________ To learn about hormone therapy, grab Claudia's FREE resource: 3-Day HRT Crash Course. In just 3 quick emails, you'll learn:

TWIRx NEWS 1. Medicare Part D Paid Nearly $588 Million for Ineligible OTC Drugs   A federal audit found that Medicare Part D sponsors made approximately $587.7 million in ineligible payments from 2021 through 2023 for medications that had effectively transitioned from prescription to over-the-counter status.   The HHS Office of Inspector General cited outdated FDA information and the lack of a clear CMS rejection timeline as major contributors.   Why it matters: This exposes a serious coordination problem across FDA data, manufacturers, CMS, health plans and pharmacy claims systems.   Pharmacists may see the rejection or payment issue at the counter, but the failure often begins far upstream.   Read the Fierce Healthcare report Read the HHS-OIG audit 2. FDA Responds to Estradiol Patch Supply Pressure   The FDA is working with six manufacturers to improve access to estradiol transdermal patches amid increased demand.   While FDA has not declared a national shortage, availability varies by product, strength and geographic area. Manufacturers are increasing production through larger batches, added shifts and expanded capacity.   Why it matters: Pharmacists are again serving as the front line of a supply-chain challenge—helping patients locate medication, coordinating with prescribers and identifying alternatives.   Read the Reuters report Read the FDA update 3. New RSV and COVID-19 Guidance Released   The American Academy of Pediatrics and American College of Obstetricians and Gynecologists have issued updated recommendations for RSV and COVID-19 protection during the 2026–2027 respiratory season.   Why it matters: Pharmacists may face conflicting recommendations, patient confusion and questions about eligibility.   Clear counseling and coordination with pediatric and obstetric providers will be critical.   Read the Pharmacy Times report SPECIAL ANNOUNCEMENT FROM OUTCOMES   A special update from Megan Urban and Outcomes.   Outcomes is highlighting new enhancements to its Rx30 pharmacy management platform, including a refreshed user experience, automated data-entry capabilities and support from a dedicated Client Success Team.   The program will explore how these updates can streamline pharmacy workflows, save time and support greater focus on patient care.   Presented by: Dalia Rios and Kaley Lester September 9, 2026 — 1:30 p.m. ET   Register here FEATURED CONVERSATION Building a Bridge to GLP-1 Access   Our featured guest is HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health.   HaVy works at the intersection of pharmacy, healthcare technology, medication affordability and prescription access.   Buzz Health operates platforms including BuzzRx, RxCompare and RxAffect, with a focus on helping connect patients, pharmacies, prescribers and prescription pricing information.   That makes today's discussion particularly timely. THE MEDICARE GLP-1 BRIDGE   CMS launched the Medicare GLP-1 Bridge on July 1, 2026, to provide eligible Medicare Part D beneficiaries access to selected GLP-1 medications for weight management.   The demonstration runs through December 31, 2027.   Eligible beneficiaries pay $50 for a monthly supply, while the program operates outside the traditional Part D payment flow through centralized prior authorization, claims adjudication and pharmacy payment.   Eligible therapies currently include:   Foundayo® Wegovy® Zepbound®   The bigger issue is not simply GLP-1 coverage.   It is how healthcare connects eligibility, affordability, prior authorization, pharmacy workflow and patient access.   The central question for today's discussion:   Can we create a medication-access system where patients know whether they can obtain and afford their therapy before they reach the pharmacy counter? CLOSING THOUGHT   The Medicare GLP-1 Bridge is more than another federal drug program.   It is a real-world test of how healthcare can better connect coverage, affordability, prior authorization and pharmacy fulfillment around high-demand therapies.   Pharmacists remain at the center of that process.   The opportunity is to use technology to move more complexity upstream—allowing pharmacists to spend less time troubleshooting prescriptions and more time caring for patients.   Our thanks to HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health, for joining us on This Week in Pharmacy.   Learn more about the CMS Medicare GLP-1 Bridge   Learn more about Buzz Health   TWIRx — This Week in Pharmacy Pharmacy Podcast Network   Amplifying the Voice of Pharmacy.

These days, we're often bombarded with messages about how to age well, optimize our daily habits, and perform at our best. It's easy to feel overwhelmed by the pressure to adopt a multi-step routine or spend a fortune on the latest peptides, supplements, or biohacks.    In this episode, Jim LaValle, RPh, CCN, is cutting through the hype and myths surrounding "performance aging." He breaks down what that term means and how we can return to the sensible, proven foundations for staying healthy over the long term.    This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/what-is-performance-aging-really-performance-longevity-series   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.   Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

Independent pharmacy owners Richard Stryker, RPh., (Bayshore Pharmacy) and Theresa Tolle, BPharm, FAPhA,  (Bay Street Pharmacy) join PQS host Rosalyn Otting, PharmD, to break down how performance-based care is reshaping pharmacy revenue. They cover the three keys to getting paid for clinical programs: prioritizing opportunities, fitting them into daily workflow, and scaling them for growth. Topics include MedSync as the anchor for clinical billing, quarterly check-ins and on-time-fill bonuses, point-of-care testing (blood pressure, A1c), pay-for-performance networks tied to Medicare Star measures, and staff buy-in strategies for rolling out new programs. The episode closes with a look ahead to 2027 Star Rating changes, including a new depression screening measure, and where pharmacists see the biggest opportunities over the next 3-5 years, from cardiovascular screenings to maternal health and community-based care.

In this Roofing Road Trips® episode, Heidi J. Ellsworth sits down with Douglas Wade, the new CEO of RPH, to discuss innovation in commercial roofing with an emphasis on proper roof and wall penetration management. Doug shares what contractors, consultants and building owners often misunderstand about rooftop penetrations and how those challenges are shaping his vision for RPH. Listeners will learn how RPH is innovating to address these challenges and delivering an overall focus on education, training and customer support.    Learn more at RoofersCoffeeShop.com!  https://www.rooferscoffeeshop.com/   Are you a contractor looking for resources? Become an R-Club Member today! https://www.rooferscoffeeshop.com/rcs-club-sign-up   Sign up for the Week in Roofing!  https://www.rooferscoffeeshop.com/sign-up   Learn more about RPH here! https://www.rooferscoffeeshop.com/directory/rph Follow Us!   https://www.facebook.com/rooferscoffeeshop/  https://www.linkedin.com/company/rooferscoffeeshop-com  https://x.com/RoofCoffeeShop  https://www.instagram.com/rooferscoffeeshop/  https://www.youtube.com/channel/UCAQTC5U3FL9M-_wcRiEEyvw  https://www.pinterest.com/rcscom/  https://www.tiktok.com/@rooferscoffeeshop  https://www.rooferscoffeeshop.com/rss  #RoofersCoffeeShop #MetalCoffeeShop #AskARoofer #CoatingsCoffeeShop #RoofingProfessionals #RoofingContractors #RoofingIndustry 

A special repeat of Talking Vision's World Braille Day special from ealier this year: Vision Australia Radio and RPH network veteran Stephen Jolley, catches up with BBC North America correspondent Gary O'Donoghue. Gary has been totally blind from a young age, and so throughout his later childhood and adult life braille has played a central role in everything he does. Tune in to hear more from Gary about braille's role in his life, making inroads as a blind journalist on the world stage, breaking down barriers and covering the latest global news from North America over the past decade for the BBC.Support this Vision Australia Radio program: https://www.visionaustralia.org/donate?src=radio&type=0&_ga=2.182040610.46191917.1644183916-1718358749.1627963141See omnystudio.com/listener for privacy information.

In this episode of The Pharmacist's Voice Podcast, I talk with Ohio pharmacist Dan Krinsky about writing, co-authoring, and editing. This is Episode 22 in the Pharmacist Authors Series. Unlike most episodes in the series, our conversation does not focus on one specific book. Dan has written and edited many types of professional content, including continuing education and journal articles, newsletters, patient education materials, business proposals, and pharmacy reference resources. Dan first appeared on the podcast in Episode 133, when we discussed his pharmacy career and pharmacogenomics. This time, writing gets the spotlight. Dan shares practical advice for pharmacists, pharmacy students, pharmacy technicians, and pharmacy professors who want to begin writing or expand their writing experience. Dan's contact information, website, and social media links  Dan Krinsky BS, MS, RPh, FAPhA on LinkedIn https://www.linkedin.com/in/dan-krinsky-bs-ms-rph-fapha-a8537a/  Dan's email dkrinsky@educare-4u.com  EduCare4U, LLC website https://www.educare-4u.com  PGx101, LLC on LinkedIn https://www.linkedin.com/company/pgx101  The Pharmacist's Voice Podcast Episode 133 featuring Dan Krinsky About Dan Krinsky B.S., M.S., R.Ph., FAPhA (July 2026) Dan is business owner, educator, entrepreneur and pharmacist who is passionate about advancing patient care and the pharmacy profession.  He owns 2 businesses:  EduCare4U, LLC, (focused on education and patient care) and PGx101, LLC (focused on pharmacogenomics education and practice implementation).  Mr. Krinsky is currently a Professor at the LECOM School of Pharmacy, serving as a lecturer, committee member, and student advisor.  He is a Fellow of the American Pharmacists Association and an active member of the Medication Management Special Interest Group.  Other ventures include working with providers to optimize patients' drug therapy; professional writing; creation of certificate training programs, and new business development.  Mr. Krinsky is Editor-in-Chief and Section Editor for the American Pharmacists Association publication 'Handbook of Nonprescription Drugs:  An Interactive Approach to Self-Care.' Mr. Krinsky's areas of expertise include community pharmacy practice, drug information, patient counseling and education, OTCs, natural products, pharmacogenomics, and developing and implementing medication therapy and disease state management programs.  His primary professional goal is to 'pay it forward', finding ways to make the profession better for the next generation of pharmacists.     Questions and abbreviated answers from our conversation How did writing become part of your professional life? Dan's first major writing project was his master's thesis in pharmacokinetics. Writing did not come naturally at first, but he discovered that he enjoyed gathering information and turning it into something useful for an audience. How can someone decide whether writing is right for them? Start with a topic you care about. Identify the audience, look for gaps in available information, and find a mentor or support network. You do not need to work alone. Should new writers start small or go directly to writing a book? Dan recommends beginning with an article, newsletter, or another smaller project when possible. Smaller projects provide quicker feedback and help writers build skills and confidence. Someone who wants to start with a book should narrow the topic, identify the audience, create an outline, set deadlines, and seek feedback early. What has Dan written? His work includes newsletters, business proposals, patient advisory leaflets, consumer health information, journal and continuing education articles, and two co-authored point-of-care resources: the Natural Therapeutics Pocket Guide and the Drug-Induced Nutrient Depletion Handbook. He has also contributed to multiple editions of APhA's Handbook of Nonprescription Drugs as an author and editor. How are writing, co-authoring, and editing different? An author creates the content. Co-authors share responsibility and need clear roles, flexibility, and communication. An editor improves accuracy, organization, clarity, and usefulness while protecting the author's voice. When should an author involve an editor? As early as possible. An editor can help shape the audience, scope, outline, organization, and flow before the author invests months in the wrong direction. Early feedback is usually easier to handle than dozens of changes at the end. How can someone find a useful topic? Pay attention to recurring patient questions, conversations, media claims, and gaps in health information. The final product does not need to be a book. It could be an article, handout, script, social media post, or educational program. What keeps people from starting? Dan identifies three common barriers: waiting to become "the expert," fear of criticism, and lack of structure. Know what you know, recognize what you do not know, and build a network that can help fill the gaps. How can pharmacists develop a writing habit? Schedule writing time, set specific goals, work backward from deadlines, and use an accountability partner. A detailed outline makes a large project feel more manageable. Where can beginners find legitimate writing opportunities? Consider professional associations, colleges of pharmacy, health systems, community pharmacies, continuing education companies, consumer health websites, and digital health companies. Build a portfolio with writing samples, areas of expertise, testimonials, and other communication experience. How long should someone give writing before deciding it is not for them? There is no single timeline. A newsletter article may take a month; a book may take 12 to 18 months. Set realistic deadlines for each project, start small, and give yourself time to learn. What is Dan's final advice for aspiring authors? Find a mentor, be patient, expect revisions, learn from feedback, and enjoy the process. Writing may not be the right path for everyone, but it can be a meaningful way to educate patients, serve the profession, and create new opportunities. Pharmacist Authors Series Episode List 2025 Pharmacist Authors Series Part 1 of 3 (June) Episode 336 with Jerry Levin, PhD, LMT - Affirm Yourself: 15 Principles to Retrain the Voice in Your Head. Part 2 of 3 (July) Episode 340 with Ashley Walker, PharmD - Expanding Your Brilliance: Creating Effortless Abundance while Navigating Business and Motherhood https://amzn.to/418hdwx Part 3 of 3 (October) Episode 353 with Sandra O. Onye, PharmD - Winning Is in My DNA: 15 Minutes of Self-Reflection https://amzn.to/48KTtn3 2024 Pharmacist Authors Series Part 1 of 3 (June) Episode 282 with Steve Leuck, PharmD - A Pharmacist's Story An Authentic Tale of True Love, Family, Addiction, and the Practice of Pharmacy Part 2 of 3 (July) Episode 288 Helen Sairany, PharmD - The We You Don't See:  Understanding the Long Shadows of Trauma Part 3 of 3 (August) Episode 293 Kim Newlove with Publishing in Doses Co-Founders Janan Sarwar, PharmD and Theary Chhim, PharmD plus audio engineer, Julie Walthers. = 2023 Pharmacist Authors Series (Part 1 of 15) June 5, Introduction to the Pharmacist Authors Series (Episode 220) (Part 2 of 15) June 9, The Pharmacist's Voice ® Podcast Episode 221:  Interview with Salam Kabbani, PharmD about her book: COVID Long-Hauler:  My Life Since COVID (Part 3 of 15) June 12, The Pharmacist's Voice ® Podcast Episode 222:  Interview with audio engineer Julie Walthers from Whole Story Studio: https://www.wholestorystudio.com/  (Part 4 of 15) June 16, The Pharmacist's Voice ® Podcast Episode 223 Interview with Erin L. Albert, PharmD on her book The Life Science Lawyer Part 5 of 15) June 19, The Pharmacist's Voice ® Podcast Episode 224 Interview with Sue Ojageer, PharmD on her children's book The Pharma Heroes:  The Power of Precision Medicine (Part 6 of 15) June 23, The Pharmacist's Voice ® Podcast Episode 225: Interview with Tony Guerra, PharmD about his Pharmacist Residency and Career Series (8 books) (Part 7 of 15) June 26, The Pharmacist's Voice ® Podcast Episode 226:  Interview with Christina Fontana, PharmD about her book Moving Beyond the Counter:  Elevating into Heart-Centered Health Care through Entrepreneurship (Part 8 of 15) June 30, The Pharmacist's Voice ® Podcast Episode 227: Interview with Jade L. Ranger, PharmD, about her book Mustard Seed Mentality: Unscripted Pearls of Wisdom from a Wife, Mother, and Entrepreneur (Part 9 of 15) July 7, The Pharmacist's Voice ® Podcast Episode 229: Interview with RDML Pam Schweitzer, PharmD and her daughter Amy Graves about their children's book Alice and Jack Hike the Grand Canyon (Part 10 of 15) July 10, The Pharmacist's Voice ® Podcast Episode 230: Interview with Cory Jenks, PharmD about his book Permission to Care:  Building a Healthcare Culture That Thrives in Chaos (Part 11 of 15) July 14, The Pharmacist's Voice ® Podcast Episode 231: Interview with Donna Bartlett, PharmD about her book MedStrong:  Shed Your Meds for a Better, Healthier You - Aging Well Through Deprescribing  (Part 12 of 15) July 17, The Pharmacist's Voice ® Podcast Episode 232:  Interview with Frieda Wiley, PharmD about her book Telecommuting Psychosis:  From Surviving to Thriving While Working in Your Pajama Pants.  Plus, we touch on her 3 children's books in development. (Part 13 of 15) July 21, The Pharmacist's Voice ® Podcast Episode 233:  Interview with Tim Ulbrich, PharmD about his book Seven Figure Pharmacist:  How to Maximize Your Income, Eliminate Debt, and Create Wealth  (Part 14 of 15) July 24, The Pharmacist's Voice ® Podcast Episode 234:  Interview with LaQuoia Johnson, PharmD about her book How Rxacism Manifests Inside the Small World of Pharmacy (Part 15 of 15) July 28, The Pharmacist's Voice ® Podcast Episode 235:  Pharmacist Authors Series wrap-up (solo show) Kim's websites and social media links ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs   ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ A Behind-the-scenes look at The Pharmacist's Voice ® Podcast © Online Course https://www.kimnewlove.com  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove  ✅ Facebook https://www.facebook.com/kim.newlove.96  ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with my coach, Dave Jackson from The School of Podcasting! Click my affiliate link: https://community.schoolofpodcasting.com/invitation?code=G43D3G  *New 12-4-25*   Thank you for listening to episode 372 of The Pharmacist's Voice ® Podcast. If you know someone who would like this episode, please share it with them!

Josh's Guests: Karen Masterson Koch - founder, ALOE LIFE Using aloe vera to improve the beauty of your skin and hair.  What are the active ingredients to look for in aloe vera vera so you know you have a product that works? Ross Pelton, RPh. - author, Alternatives In Cancer Treatment Published by Simon & Schuster. Board of Governors The National Health Federation. A long time wellness researcher offers fresh updates on healing find us at: www.HeresToYourHealthWithJoshuaLane.com  

What Nobody Is Telling You About Peptide Stacks and GLP-1s Peptides are everywhere. Stacks are trending. Influencers are dosing on camera. Clinicians are ordering compounds off websites. And somewhere in all of it, the actual science of how these molecules work — and what can go wrong when you combine them without testing — is getting completely lost. Dr. Terri sits back down with Jim LaValle, RPh, CCN, for a no-nonsense conversation on the state of the peptide and GLP-1 landscape in 2025. They cover peptide stacking, why combining untested compounds in a single vial is not precision medicine, the black market GLP-1 problem, what retatrutide actually is and why so many people are injecting a version of it that has never been tested for human safety, and what's happening to patients — and clinicians — who cut corners. They also go deep on GLP-1s done right: why 30% of Dr. Terri's patients are on one, why the ones who thrive are the ones who do the work, and why a thinner person can still be metabolically sicker than before they started. If you or someone you love is using peptides or GLP-1s — or thinking about it — this is the episode to share. What you'll discover: Why peptide stacks sound like precision medicine but are actually dartboard medicine without stability and efficacy data [04:02] What "research use only" and "physician use only" actually means on a label — and why injecting it is a gamble [09:34] The regulatory reality: why rogue labs are giving the FDA the ammunition to shut down all compounding [10:20] Retatrutide: what the three-mechanism GLP-1 actually is, why it's not legally available yet, and what patients are actually injecting when they think they're on it [25:31] Dr. Terri's clinical red flag: three postmenopausal patients on black market retatrutide all presenting with unexpected spotting [28:04] Why GLP-1s done wrong are creating scurvy, bone loss, hair loss, and skinny fat — and what done right actually looks like [33:14] How to protect gut integrity, lean mass, and metabolic rate while on a GLP-1 [32:48] Why food noise comes back every time the dose drops — and how addressing sympathetic dominance may be the real fix [38:07] The full circle: GLP-1s, nervous system, dopamine, and why stress is what created the craving in the first place [38:07] A tool used wrong is still a tool used wrong. Do this right or don't do it. The Dr. Terri Show is presented by EVEXIAS Health Solutions.Learn more and find a provider near you at evexias.com Connect with Dr. Terri:

Navigating Treatment, Access, and Outcomes in Idiopathic Hypersomnia On this episode guest host Denise Wolff, PharmD, CEO & Founder of Denise & Co., LLC, welcomes Zachary Contreras, PharmD, RPh, Director of Pharmacy Benefits, Sharp Health Plan, for a discussion on idiopathic hypersomnia (IH), a chronic neurological sleep disorder that remains widely underrecognized despite its profound impact on patients' lives. Together, they explore the challenges of diagnosing IH, including a diagnostic delay that can exceed a decade, the significant burden the condition places on work, relationships, education, and overall quality of life, and the reasons many patients remain invisible within healthcare systems. The episode highlights practical steps health plans can take today to reduce barriers to care, improve long-term outcomes, and help patients with idiopathic hypersomnia receive the diagnosis and treatment they need sooner. Sponsored by Jazz Pharmaceuticals.

RPH is back!!! Co-hosts Melanie Yazzie and Elena Ortiz discuss Steven Spielberg's latest summer blockbuster. Empower our work:  GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter:  https://www.therednation.org/   Patreon   https://www.patreon.com/redmediapr

Integrative Care Impact and the Expanding Role of the Pharmacist | TWIRx Today's episode of This Week in Pharmacy explores two major opportunities shaping the future of the profession: the growth of holistic and integrative pharmacy services inside community pharmacies, and the expanding demand for pharmacists across the business, insurance, and PBM sectors. In our first segment, Todd Eury welcomes special guests Robert Kress, RPh, and Dr. Bianca Bradshaw, PharmD, owner of Elmore Pharmacy in Red Bluff, California. Together, they discuss the tremendous opportunity for independent pharmacies to build holistic and integrative health departments that respond to growing consumer demand for natural products, supplements, wellness solutions, and personalized care. Dr. Bianca Bradshaw, PharmD https://www.linkedin.com/in/bianca-bradshaw-141092205/ Patients are increasingly seeking more natural approaches to health, but they still need trusted clinical guidance. Community pharmacists are uniquely positioned to help patients evaluate products, avoid harmful interactions, understand evidence, and develop safer, more effective wellness plans. This conversation explores how pharmacies can create new service lines, improve patient relationships, and establish sustainable revenue opportunities through integrative care. In our second segment, Dr. Bonnie Hui-Callahan, PharmD, returns to the show to discuss career opportunities for pharmacists within Judi Health and Capital Rx, as well as the broader business and insurance side of pharmacy. Dr. Bonnie Hui-Callahan, PharmD https://www.linkedin.com/in/bonnie-hui-callahan/ As PBMs continue to evolve, new-generation models are creating demand for pharmacists who understand clinical care, benefits, formulary strategy, patient access, data, and healthcare economics. Bonnie shares why pharmacists will remain essential as PBMs transform and why the profession should look beyond traditional dispensing and clinical practice roles when considering future career paths. Today's episode is sponsored by Independent Pharmacy Cooperative and SuiteRx. Listen to This Week in Pharmacy on the Pharmacy Podcast Network.

When most people think about hormone balance, they think about estrogen. But according to pharmacist and hormone expert Carol Petersen, progesterone may be the hormone women need most—and the one most often overlooked. In this episode, Dr. Jen sits down with Carol to discuss the critical role progesterone plays in perimenopause, menopause, PMS, heavy menstrual bleeding, fertility, sleep, mood, and nervous system health. They explore why progesterone deficiency often begins long before menopause, how chronic stress impacts hormone production, and why many women are being undertreated or improperly balanced with hormone therapy. This conversation offers a fresh perspective on bioidentical hormones and what true hormone balance really looks like.Carol Petersen, RPh, CNP, is a compounding pharmacist, certified nutritional practitioner, and founder of The Wellness by Design Project. With more than three decades of experience specializing in bioidentical hormone replacement therapy, Carol has become a respected voice in women's health and personalized medicine. Through education, coaching, writing, and clinical consultation, she helps women better understand hormone balance, navigate perimenopause and menopause, and make informed decisions about their health.This Episode is brought to you by Zeolite:Zeocharge is a "smart binder" made from supercharged zeolite powder, designed to help naturally remove unwanted toxins—like heavy metals and microtoxins—without stripping away the essential nutrients you need to thrive.Support your overworked system and find an exclusive discount for our listeners at: zeolitelabs.com/zeolitediscountWebsite: https://thewellnessbydesignproject.com Instagram: https://www.instagram.com/carolpetersen17 Facebook: https://www.facebook.com/WellnessCarol Podcast: https://open.spotify.com/show/4Ai0M1ZIgucAOjCdSypvVv YouTube: https://www.youtube.com/@thewellnessbydesignproject  PODCAST: Thank you for listening please subscribe and share! Shop supplements: https://healthybydrjen.shop/CHECK OUT a list of my Favorite products here: https://www.healthybydrjen.com/drjenfavoritesFOLLOW ME:Instagram: https://www.instagram.com/integrativedrmom/Facebook:  https://www.facebook.com/integrativedrmomYouTube: https://www.youtube.com/@integrativedrmomFTC: Some links included in this description might be affiliate links. If you purchase a product through one of them, I will receive a commission (at no additional cost to you).  I truly appreciate your support of my channel. Thank you for watching! Video is not sponsored.DISCLAIMER: This podcast does not contain any medical or health related diagnosis or treatment advice. Content provided on this podcast is for informational purposes only.  For any medical or health related advice, please consult with a physician or other healthcare professionals. Further, information about specific products or treatments within this podcast are not to diagnose, treat, cure or prevent disease.

Ella Loneragan speaks with Nadia Budihardjo about a new office building project aiming to bring arts organisations into the city. Plus: EPA's decision on Rinehart's gas plant; RPH's construction costs; and Westbridge's $10m Busselton buy.

RPH is back! Co-hosts Elena Ortiz and Melanie Yazzie discuss Ramona Emerson's Exposure (2024) Check out our earlier episode on Ramona's previous novel, Shutter (2022)  Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon www.patreon.com/redmediapr

Only roughly 50% of new GLP-1 prescriptions were getting approved for coverage in 2023. From a plan sponsor's seat, that looks like pharmacy trend spiking 9%, 12%, even 20% year over year. From a pharma manufacturer's seat, it's half their prescriptions not getting filled. Same market, opposite problems — and that's exactly the lens this episode flips on. In this episode, Stacey Richter speaks with Ophelia Johnson, who built new business channels for a pharmaceutical manufacturer that created the GLP-1 boom and has since launched a consulting practice at e-fi.works, about how cash pay models work from the inside — coupon platforms, telehealth channels, white label pharmacy models, and employer carve-outs — and where the new fees are hiding. WHAT YOU'LL LEARN ✅ How the Inflation Reduction Act, PBM legal scrutiny, drug shortages, and the compounding bypass converged with ~50% GLP-1 prior auth denial rates in 2023 to push pharma into building cash pay channels that cut the PBM out entirely ✅ How the savings coupon model works: manufacturer buys the patient down to a flat transparent cash price via platforms like GoodRx, pays a fixed per-script fee instead of a PBM rebate, and the coupon platform makes the pharmacy whole — transparent math, no black box ✅ How the telehealth channel and white label pharmacy models extend the distribution chain beyond retail — and why shipping costs, credit card fees, dispensing fees, and new supply chain partners create gross-to-net and revenue leakage risk for manufacturers not built for it ✅ Why "direct to employer" is a misnomer: PBM contracts prohibit pharma from selling directly to self-insured employers, so third-party transparent administrators have emerged — but plan sponsors need to run the math first, given ERISA complications and PBM contract leverage ✅ How PBMs are now charging fees for hub-like patient support services to manage the exact prior auth complexity they created — a Whack-a-Mole shift of profitability that everyone needs to map before signing anything ✅ Ophelia's three-part practical advice: map the full patient journey and all ecosystem player incentives before building any new model (pharma); treat affordability as a clinical risk factor (clinicians); demand auditable medication abandonment data rather than settling for rebate yield metrics (plan sponsors) WHY THIS MATTERS If collaboration is the next innovation, everyone has to understand the incentives of every player in the ecosystem — not just their own. The same 50% of unfilled GLP-1 prescriptions that looks like runaway pharmacy trend from a plan sponsor's seat looks, from a manufacturer's seat, like half their market going dark — and both sides are making moves that affect each other. Understanding those moves, where fees are being layered on, and when fair profit tips into what Stacey calls profiteering is what this episode maps. TUNE IN NEXT WEEK Next week is the 401-level companion to this one — Stacey goes solo on the PBM and GPO contracting mechanics behind why cash pay became a thing, and why cheaper or better drugs can inexplicably end up off formulary or buried under prior auth. === LINKS ===

Well-designed rotation experiences are essential to developing competent and confident student pharmacists and residents. This course discusses how to structure rotations, align with institutional expectations, and create meaningful schedules, activities, and deliverables that balance service and learning, while introducing principles of deliberate practice to support ongoing skill development. You will gain practical strategies for designing engaging, well-organized, high-impact experiential learning experiences  HostKate Newman PharmD,Director of Experiential EducationClinical Associate Professor, Pharmacy PracticeSouthern Illinois University - EdwardsvilleGuestMayank Amin, PharmD, RPH, MBAPharmacistOwner, Skippack Pharmacy Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1.  Describe key elements of effective rotation design, including structure, expectations, and learning activities. 2. Identify strategies to create engaging and high-impact rotation experiences for pharmacy learners. 0.1 CEU/1.0 HrUAN: 0107-0000-26-246-H99-PInitial release date: 6/17/2026Expiration date: 6/17/2029Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.The examples shared in this episode are intended to illustrate approaches to experiential learning, service development, and patient care innovation and are not endorsements of any specific service, product, or practice model. Certain examples discussed may no longer be viable, appropriate, or permissible under current regulatory requirements. Pharmacists should exercise professional judgment and ensure compliance with applicable laws, regulations, payer requirements, and evidence-based standards when evaluating or implementing patient care services.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

RPH is back! Co-hosts Elena Ortiz and Melanie Yazzie discuss Cannupa Hanska Luger's Surviva: A Future Ancestral Field Guide (2025), a hybrid art piece/survival manual exploring indigenous futurism, decolonization, and relationality through redacted military text and Indigenous artwork. Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon www.patreon.com/redmediapr

"There are a lot of specifics that nurses need to keep in mind as they are administering this herpes simplex modified virus to patients because accidental exposure is of concern both to the patient, to their family members, as well as to healthcare workers. I always recommend nurses wear personal protective equipment, such as a gown, safety glasses, gloves, and/or a face shield," Heidi Finnes, PharmD, RPh, BCOP, director of clinical ambulatory practice at Mayo Clinic and assistant professor of pharmacy at Mayo Clinic Alix School of Medicine in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about oncolytic viral therapy.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 29, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of oncolytic viruses to treat cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 338: High-Volume Subcutaneous Injections: The Oncology Nurse's Role Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 273: Updates in Chemotherapy and Immunotherapy ONS Voice articles: Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy Oncolytic Virus Kills Tumor Cells While Supporting T Cells What Nurses Need to Know About Talimogene Laherparepvec for Advanced Melanoma Clinical Journal of Oncology Nursing articles: Intralesional Therapy: Consensus Statements for Best Practices in Administration From the Melanoma Nursing Initiative Safe and Effective Standards of Care: Supporting the Administration of T-VEC for Patients With Advanced Melanoma in the Outpatient Oncology Setting Oncology Nursing Forum article: Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma ONS book: Guide to Cancer Immunotherapy (second edition) ONS clinical practice resource: Safe Handling of Oncolytic Viruses ONS Huddle Card: Immunotherapy Association of Community Cancer Centers (ACCC) Drugs@FDA Hematology/Oncology Pharmacy Association (HOPA) Network for Collaborative Oncology Development and Advancement (NCODA) Patient Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "[Oncolytic viruses] can have direct lysis to the tumor cells themselves, or they can cause immunogenic activation. They release tumor-associated antigens and then proinflammatory signals, so think of T cells, natural killer cells, those sorts of things, that can convert to immunologically cold tumors. Those are tumors that are immune silenced into hot tumors which are now immune activated. By doing that, they recruit those T cells and other cells to the area to attack both the primary tumors. But that's also thought to be how they work on distant or noninjected sites as well. This immunomodulatory capacity has led to the reclassification of oncolytic viruses as a form of cancer immunotherapy. So, think of it kind of similarly to how we think of immune checkpoint inhibitors in recruiting immune cells and leaving our immune system in the on position. This is also kind of a form of immunotherapy." TS 4:35 "One of the toxicities I know that is of significant concern to patients, family members, and healthcare workers is the incidence of herpes infections. Systemic herpetic infections are extremely rare and usually more common in patients who may be immunocompromised. In patients who also have other immune-related diseases—such as vitiligo, vasculitis, pneumonitis, sometimes worsening psoriasis—because you're mounting an immune response with these types of things, sometimes you can see a worsening of those types of immune symptoms. But for the most part, these types of side effects are very well tolerated in most patients." TS 9:07 "Talimogene is generally transmitted via bodily fluids or touch. It's not airborne. Herpes simplex virus isn't an airborne type of virus. Another thing to consider is where are you going to inject this? Are you going to do this in your infusion therapy unit? Are you going to do it in a dedicated room? Who's going to escort the patient to the room? How is the virus going to arrive at the room? How will you clean the room and all of the laboratory equipment or any of the exam tables that may be in there? I think having all of that discussed and assigned mitigates the consternation that can sometimes occur—the fear that occurs with administering a virus that is thought to be fairly communicable." TS 15:44 "Helping patients understand how this works [is important] because hearing that you're receiving a virus, particularly a herpes simplex virus, can be scary to a patient. I think understanding that it's modified or essentially we're taking the parts out of it so that we can directly inject a portion that recruits immune cells to that area, because the goal is for the oncolytic virus to attack cancer cells and then destroy them by triggering an immune response in the body." TS 20:51 "Sometimes patients are very concerned about urine in the toilet, bodily fluids, kissing loved ones, holding hands, hugging, you know, am I going to infect my loved one because I'm getting this type of an oncolytic virus therapy? I like to reassure patients that they can continue to hold hands and hug their loved ones as normal. Viral DNA is usually only present on the injection site. And as I mentioned previously, we want to cover that injection site with an occlusive dressing, at least with talimogene, for up to seven days. And particularly, if those injection sites are at all oozing or weeping, active virus is usually only on that injection site itself." TS 24:14

Season 10, Episode 14: Optimizing Access Through OOLD In this episode of the PQI Podcast, we explore Oncology Optimized Limited Distribution (OOLD) and its growing importance within patient-centered oncology care. Guests Jonas Congelli, RPh, and Ken Komorny, PharmD, BCPS, discuss how distribution models impact oncology practices, care coordination, and the patient experience, while highlighting the critical role of medically integrated pharmacy services in supporting timely therapy initiation, education, adherence, and adverse event management. Jonas shares the vision behind OOLD and how medically integrated oncology teams help streamline care for patients receiving oral anticancer therapies. Ken provides insight into Moffitt Cancer Center's experience navigating operational, financial, and policy challenges related to specialty pharmacy access, including advocacy efforts. The conversation also highlights how oncology practices, manufacturers, and advocacy organizations can work together to preserve coordinated care models that prioritize patient safety, communication, and continuity of care. Throughout the episode, the discussion reinforces the value of multidisciplinary collaboration and innovation in shaping the future of oncology pharmacy practice and improving outcomes for patients nationwide. Learn more about NCODA and NCODA's OOLD initiatives here.View the poster Ken discussed here.

Please visit answersincme.com/860/240201372-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jeffrey Habert, MD, CCFP, FCFP and Maria Anton, RPh, BSc, PharmD. In this activity, experts in type 2 diabetes discuss guideline-recommended goals of treatment and strategies to develop personalized plans that incorporate the latest GLP-1–based therapies. Upon completion of this activity, participants should be better able to: Propose guideline-recommended goals of treatment for adults with T2D; Formulate personalized, evidence-based treatment plans for T2D; and Apply practical strategies for the initiation and integration of contemporary therapies for adults with T2D.

RPH is back!! Co-hosts Elena Ortiz and Melanie Yazzie tackle the Disney+ television adaptation of Marvel's comics character Echo. Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon https://www.patreon.com/redmediapr  

RPH is back! Red Power Hour co-hosts Melanie Yazzie and Elena Ortiz tackle a collection of stories, Love after the End An Anthology of Two-Spirit and Indigiqueer Speculative Fiction Watch the video edition on The Red Nation Podcast YouTube channel Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon https://www.patreon.com/redmediapr

Join host Dr. Britney Woods, PharmD, Sr. Manager of Community Pharmacy at McKesson Health Mart, for a compelling conversation about the power of automation in independent pharmacies. This episode features special guests Faisal Adam, Pharmacist at Mark's Pharmacy, and Alisha Nanji, Pharmacy Manager with McKesson Canada, who share their firsthand experiences on how thoughtfully implemented automation can help transform daily operations, ease the workload for pharmacy teams, and elevate patient care. Listen in as they explore practical strategies for unlocking real capacity and efficiency in the pharmacy setting and discover how embracing technology can help make a meaningful difference for both your staff and patients.HostBritney Woods, PharmDSr. Manager, Community PharmacyMcKesson / Health MartGuestsFaisal Adam, PharmDPharmacistMark's PharmacyAlisha Nanji, HBSc, BSc Phm, RPh, (ON/NB)Pharmacy ManagerMcKesson CanadaResourcesYou can learn more about McKesson Pharmacy Automation Services here: https://www.mckesson.com/automation/ ReferencesHealth Mart Pharmacies can access Health Mart University (HMU) for:Helpful CE courses and more on inventory management and workflowHealth Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

**Producer's note: This is the first half of a two-part episode.  The second half will be available to patrons of Red Media and on YouTube channel for free. Sign up today for as little as $2 a month for access to all the great bonus content! RPH is back! Indigenous scholar Jodi Byrd joins co-hosts Melanie Yazzie and Elena Ortiz for another episode on Ryan Coogler's Sinners (2025) Watch the video edition on The Red Nation YouTube channel https://youtu.be/KUMpfJpzrOs Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon https://www.patreon.com/redmediapr

Acne doesn't end when the breakout does — and this episode is all about treating the full journey. In this special Neutrogena-sponsored episode of the Science of Skin podcast, board-certified dermatologists Dr. Ted Lain and Dr. Patti Farris sit down with Rabab Hussain, PharmD, RPh. from Neutrogena's Translational Science team to break down the brand-new Evenly Clear acne line — a dermatologist-informed collection designed to tackle both active acne and post-inflammatory hyperpigmentation (PIH) in one cohesive regimen. Together, they dive deep into the science behind each product, including: Evenly Clear Acne Cleanser — 2% salicylic acid + polyhydroxy acid (PHA/gluconolactone) for barrier-respecting exfoliation Evenly Clear Acne Gel Moisturizer — 0.5% salicylic acid, N-acetylglucosamine, and a pre & postbiotic complex to support the skin microbiome and fade post-acne marks Evenly Clear Acne Cleansing Mask — 3.5% benzoyl peroxide + bentonite clay for oily, acne-prone skin on the face and body Evenly Clear Retinoid — 0.1% adapalene for acne treatment, exfoliation, and anti-pigmentation benefits Evenly Clear Acne Exfoliant — an AHA + BHA + PHA trifecta with glycolic acid, salicylic acid, mandelic acid, and PHA for multi-acid exfoliation with tolerability in mind Evenly Clear Clarifying Spray — a stabilized hypochlorous acid spray for on-the-go skin support Whether you're treating teens, adult women with hormonal acne, or patients with skin of color concerned about dark marks, this episode gives you the clinical rationale to confidently recommend OTC options — no prior authorization required. Topics covered: acne treatment regimens, post-inflammatory hyperpigmentation, skin barrier repair, the skin microbiome and dysbiosis, retinoids OTC, chemical exfoliants, hypochlorous acid, benzoyl peroxide tolerability, and building a complete acne skincare routine. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment. See omnystudio.com/listener for privacy information.

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Kelli Stovall, RPh, EMBA, - IPC Amantha Bagdon - RxPost Dixie Leikach - PeerRx Dr Erin Parsons, PharmD - LSPedia Sally Rafie, PharmD Thank you to Independent Pharmacy Cooperative (IPC) for sponsoring this episode!

This Week in Pharmacy – 04-06-2026 Sponsored by Outcomes and Independent Pharmacy Cooperative (IPC) On this episode of This Week in Pharmacy, we dig into another high-impact week across the profession with TWIRx news, practice transformation, oncology leadership, pediatric research innovation, and a look ahead to one of specialty pharmacy's biggest gatherings of the year. This week's episode is powered by our sponsors, Outcomes and Independent Pharmacy Cooperative (IPC), organizations continuing to support independent pharmacy innovation, patient engagement, and pharmacy performance. In the TWIRx News segment, we cover four important stories shaping the national conversation in pharmacy. First, we discuss the federal fraud case involving a Dearborn Heights pharmacy owner who pleaded guilty in a $1.9 million health care fraud scheme. According to the U.S. Department of Justice, Rabih Hamdan admitted to conspiring to submit false claims for prescription drugs that were either medically unnecessary or never actually dispensed, impacting Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Federal prosecutors say the fraudulent claims totaled at least $1.9 million over a five-year period. Next, we look at oncology pharmacy leadership through the lens of Amy Seung, who is stepping into the HOPA presidency during a period of rapid acceleration in cancer care. In Pharmacy Times, Seung describes a practice environment where new approvals, indications, toxicity data, and clinical questions are arriving weekly or even daily. She positions HOPA as a key bridge between emerging science and real-world implementation, with this year's conference emphasizing bispecific therapies, real-world evidence, supportive care, and toxicity management. We also spotlight a powerful research update from the UNC Eshelman School of Pharmacy, where professor David Drewry and student researchers are advancing work on diffuse intrinsic pontine glioma (DIPG), an aggressive pediatric brain cancer with limited treatment options and an average life expectancy of about one year after diagnosis. The team is using an open-science model to accelerate discovery while keeping future therapies more affordable, and they are working with M4K Pharma to advance an ALK2 inhibitor toward a Phase 1 clinical trial. Finally, we feature a practice transformation story from Drug Topics: Gregg Jones, MBA, RPh, made the leap from corporate pharmacy leadership to launching Compass Core Pharmacy, described as Rhode Island's first cost-plus pharmacy model. The cash-only model focuses on generics, uses AI-driven ordering, serves a growing veterinary segment with more than 1,400 pet prescriptions, and operates as a CLIA-waived pharmacy offering point-of-care testing. It is a compelling example of how pharmacists are reengineering care delivery outside the traditional reimbursement framework. We are also getting ready for Asembia 2026 in Las Vegas, where the Pharmacy Podcast Network will once again provide press coverage with support from Clearway Health. You can find us at booth 1805, where we'll be capturing conversations that matter across specialty pharmacy, access, patient support, innovation, and care delivery. Our first featured interview is with Nick Baird, Director of Marketing with Outcomes, where we will explore the growing role of pharmacy engagement, patient activation, and value creation in community-based care. Our second interview features Dr. Jen Hammons, PharmD, DrPH, with Health Wagon, a vital community healthcare organization dedicated to serving medically underserved patients through an expanding network of care. In 2024 alone, Health Wagon served 7,291 unique patients through 21,615 patient encounters, supported by five mobile health units, three stationary clinic sites, a dental clinic, a vision clinic, and a pharmacy. Known for hosting one of the nation's largest health outreach efforts of its kind, Health Wagon continues to expand its impact through the dedication of staff, volunteers, trustees, partners, donors, and supporters. Join us as we connect the week's top headlines to the broader transformation underway in pharmacy practice, policy, specialty care, and community health. To learn more, follow the Pharmacy Podcast Network and stay connected as we head into Asembia 2026.

Recovery is crucial for our bodies to perform at their best — and strategic recovery practices can both elevate athletic performance and speed healing when injury happens.   In this episode, Jim LaValle, RPh, CCN, discusses recovery strategies for two groups of people: those who train hard and need to be ready for their next workout, and those who are coming back to fitness following an injury. Learn lifestyle approaches for supporting your recovery so you can continue moving and seeing results from your efforts.   This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/train-hard-recover-harder-advice-for-bouncing-back-performance-longevity-series   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.    Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

This episode of Diabetes Care Conversations explores the professional journeys of two certified diabetes care and education specialists (CDCES), Mayra Cantazaro, DNP, FNP-BC, BC-ADM, CDCES, and Liseli Mulala, RPh, MPH, PhD, CDCES, BCMTMS. The conversation illuminates how careers in diabetes care are often shaped by deeply personal experiences, mentorship, and unexpected opportunities rather than a straight path. Mayra and Liseli discuss the rewards of the profession—from meaningful patient connections and culturally responsive care to interdisciplinary collaboration and community impact. The guests explore how the field has evolved, particularly with advancements in technology, a shift toward patient-centered care, and growing opportunities for leadership and innovation. Listeners will come away inspired to embrace uncertainty, seek mentorship, and embrace the diabetes care journey. Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Peptides, stem cells, exosomes, plasmapheresis — these advanced treatments are gaining traction with research that reveals their regenerative and longevity potential. As these therapies become more accessible, they'll offer new possibilities for those seeking innovative and proactive approaches to their health.   In this episode, Jim LaValle, RPh, CCN, delves into the science behind each of these cutting-edge treatments, exploring their uses, key considerations for using them, and the potential they hold for supporting longevity, addressing chronic illnesses, and more. He also offers insights on their current availability and how he sees their role in medicine expanding in the years ahead.    This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/peptides-stem-cells-exosomes-and-more-a-look-at-advanced-therapy-options   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.    Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

Nutrients play an essential role in overall health and well-being, yet many of us are deficient in some foundational ones — vitamin D and magnesium, for instance — due to our modern diets and lifestyles. Foundational supplements are important for bridging these gaps and getting us to a better place. But what about optimization once we've established a solid foundation? What are advanced options for elevating our health even further?   In this episode, Jim LaValle, RPh, CCN, shares the top supplements he'd recommend if you're looking to take your supplement regimen to the next level. He also discusses some of the current innovations in supplementation and how they're being designed to provide more targeted solutions.   This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/taking-your-supplement-regimen-to-the-next-level-performance-longevity-series   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.   Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

Sexual health is about more than performance — it can be a major indicator of overall health. It's a reflection of your overall vitality, including the balance of your hormones and even your cardiovascular status.   In this episode, Jim LaValle, RPh, CCN, explains the critical links between sexual health and overall well-being, emphasizing that it's not a topic to shy away from addressing if you're experiencing issues. He dives into the specific areas of health that are connected to sexual desire and function, and speaks to the roles that medications, therapeutic treatments, and lifestyle strategies play.    This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/how-sexual-health-is-connected-to-overall-well-being-performance-longevity-series   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.   Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

RPH is back! Co-hosts Elena Ortiz and Melanie Yazzie tackle the almost three-decade-old classic, Smoke Signals (1988),the first major motion picture written, directed, and acted all by Native people.   Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreonhttps://www.patreon.com/redmediapr

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Darryle Tillman, RPh & John DeJames Jonathan Ference PharmD Jake Reckenbauher Dr Gavin Merin & Angela York - Value Drug Tom DePietro

RPH is back! Co-hosts Elena Ortiz and Melanie Yazzie tackle the latest installment of the Avatar franchise.  Watch the video edition on The Red Nation Podcast Youtube channel

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Margie Lydon - Value Drug Company Darren Mensch, PharmD, BCPS, BCACP Hayleigh Monroe - P4 Pharmacy Student Mayank (Dr. Mak) Amin, PharmD, RPh, MBA  Todd Laser - Value Drug Company Jonathan Adly - TJM Labs  Jennifer (Pekich) Urso  

If your mitochondria aren't functioning well, then your metabolism isn't going to either. In fact, these critical cell powerhouses play a role in nearly every function of the body. As research has revealed more about this, mitochondrial health has gained mainstream attention, with people interested to know what they can do to support this essential area of their health.    In this episode, Jim LaValle, RPh, CCN, delves into the role of mitochondrial health in overall well-being and longevity. He explores its effects on metabolic health and shares the health practices that can help improve mitochondrial function.    This episode of Life Time Talks is part of our series on Performance and Longevity with MIORA.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/power-up-your-mitochondria-a-look-at-mitochondrial-health-performance-longevity-series/   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.   Life Time provides administrative, non-clinical support to MIORA as well as services and amenities related to general wellness and fitness; Life Time does not provide medical advice, diagnosis, treatment or care.

Let us chat about today the inches all around us and also about how there is no market in healthcare all at once in this show. Today I am talking with Ivana Krajcinovic. And let me give you some examples of the inches. Two members of a plan get infusions at a hospital. And if these two members had gone down the street to get their infusions, the total cost of the two of them would have been $1 million less … $1 million less! How many inches is a million dollars? For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Or the examples Ivana Krajcinovic talks about coming up where an independent practice was charging $135 for a chemo infusion and the hospital down the street was charging for the same exact drug, by the way—the same exact infusion—$13,560 … $135 versus $13,560! We talk about affordability in this country? Member's paying coinsurance off that 13K, by the way. And if you're doing the math at home, that is a 10,000% markup. Or if we start from the Medicare price, it was a 40,000% markup. Then there's another example that Ivana talks about where a plan member went to a hospital and got a $90,000 bill for a series of infusions that, again, down the street would have been $185—all in. Inches much? So, it's pretty clear why the show is part of "The Inches Are All Around Us" series. Why do I say this is part of the "No Market" series? Because look, functioning markets rationalize prices. That's just what they do. So, if you have two places in the exact same geography and one of them is charging 500 times or whatever the other one, you don't have a market if they're both still in business a year later. Ongoing wild price variations is a big tell that there's no market to be had. Another tell, though, is that carrier networks, who are supposed to be the demand curve here—or at least that's what their marketing says or what we are all kind of led to believe—they advertise as high-value networks, right? The fact that any given network experiences essentially no business repercussions for spending a million dollars extra of its plan sponsors' (its customers') money—because that's who's paying for this, the self-insured employer or union, at the end of the day—and the network, the carrier network doesn't lose business as a result … Right? Listen to the show from last week with Jacob Asher, MD (Take Two: EP398) about the carrier nonmarket and why this is the case. But bottom line, if anyone is waiting on a market to constrain prices for them, that is very magical thinking. Where this whole thing is gonna wind up, by the way, is with my guest today, Ivana Krajcinovic, suggesting a roadmap to make a whole lot more likely that you'll pay $135 for an infusion instead of 13 grand. For more on this, do go back and listen to the show with Keith Hartman, RPh, by the way. We teed this off a couple of years ago. That was episode 369. But in Ivana's upcoming roadmap that you're gonna hear about (just doubling down on the spoilers—if I'm gonna do something, I might as well do it well), but in that roadmap, direct contracts with indie practices will feature a starring role. I'm telling you this because if you're one of those folks that listens to like 23 minutes of any given podcast and then bails, make sure you make it to around the 30-minute mark of the show. As I have said several times already, my guest today is the incomparable Ivana Krajcinovic, the outgoing vice president of healthcare delivery at UNITE HERE HEALTH. Ivana has just retired, but she spent over three decades with her team protecting the health and the hard-earned wages of 230,000 hospitality workers. She is exactly the kind of "dangerous expert" that we love to have on the show—someone with the wisdom about how the system actually works and the articulate willingness to talk about it. Okay … so, this conversation about the inches and the nonmarket for infusions specifically in this country, for more information, do go back and read the really excellent Bloomberg News exposé by John Tozzi. It's a really good article, and you'll see everything that we talk about today in writing with all the fact-checking that one would expect from Bloomberg News. So, okay … what we'll do in this episode is, first, we're gonna talk about the infusion nonmarket, the inches and its implications, such as an infusion costing 500 times Medicare when there are 1.5x Medicare options in the same exact health system. Sometimes I just can't even with some of this stuff. But another nonmarket tell, again, is that carrier networks are still in business. We talk all about that. What happens next in this episode is we deconstruct the roadmap that Ivana used to fight back, which starts with (no surprises) drilling into data and ends with direct contracting with independent doctors. And how that happens is by carving out utilization management so that there is site-of-care steerage. So, this is a conversation about fiduciary duty. It's a conversation about transparency, the power of collective action. This podcast is sponsored by Aventria Health Group with an assist from Payerset. And I thank Payerset very much for the financial support. Also mentioned in this episode are UNITE HERE HEALTH; Jacob Asher, MD; Keith Hartman, RPh; Stan Schwartz, MD; ZERO.health; John Tozzi; Aventria Health Group; Payerset; Cora Opsahl; 32BJ Union Health Fund; Jonathan Baran; Peter Hayes; Erik Davis; Autumn Yongchu; Brian Cotter; Bright Spot Insights; John Quinn; Mark Newman; Nomi Health; Preston Alexander; Health Here; Ann Lewandowski; HealthCheck360; Sam Flanders, MD; Shane Cerone; Kada Health; and Cristin Dickerson, MD. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, recently retired as vice president for healthcare delivery at UNITE HERE HEALTH (UHH), a national Taft-Hartley Fund that purchases healthcare for over 200,000 unionized hospitality workers and their families. Combining her training as a health economist with more than 30 years working directly with immigrants and the working poor, Ivana oversaw a wide variety of projects. She has deep expertise in engaging participants, ranging from benefit education to chronic disease self-management, as well as in developing peer-to-peer programs. Ivana led a team whose challenge was to radically bend the cost curve while maintaining quality coverage as every dollar that UHH spends on healthcare is a dollar that could go to a worker in wages—higher wages that are likely to do more for workers' health than increasing spending on their healthcare. Ivana and her team have utilized narrow networks, value-based contracts, and direct contracting and have established health centers designed for their members. Ivana has a PhD in economics from Yale University and is the author of From Company Doctors to Managed Care: The United Mineworkers' Noble Experiment (Cornell University Press).   00:00 $135 vs $13,560: How infusion drug prices play into the "Inches All Around Us" series. 02:02 How infusion drug pricing fits into the "No Market" series. 03:19 A roadmap and more episodes on this topic. 04:36 Introducing this week's expert, Ivana Krajcinovic, PhD. 05:10 A must-read Bloomberg News article on infusion pricing. 05:33 An overview of what to expect from this episode. 06:54 The first tell of the infusion nonmarket. 07:41 The price variations that Ivana has seen in the infusion nonmarket. 11:39 How hospital spend affects wage increases affects patients and employees twice over. 12:04 EP373 with Cora Opsahl. 13:43 The second tell of the infusion nonmarket. 14:33 Take Two: EP398 with Jacob Asher, MD. 14:55 EP483 with Jonathan Baran. 16:15 Why networks are apathetic to this pricing discrepancy. 17:55 The factors that play into the nonmarket issue of infusion drug pricing variations. 18:26 EP475 with Peter Hayes. 19:18 EP370 with Erik Davis and Autumn Yongchu. 19:45 Are pricing discrepancies easy to spot? 22:38 Where we have power in a nonmarket situation. 23:22 A recap of the advice in the show so far. 23:39 EP493 with John Quinn. 23:41 EP496 with Mark Newman. 25:51 How you place pricing pressure on an entity. 28:47 EP482 with Preston Alexander. 29:34 How an improved market creates time for better care coordination. 30:52 EP486 with Stan Schwartz, MD. 33:23 The fourth part of the roadmap. 36:41 EP492 and EP490 with Sam Flanders, MD, and Shane Cerone. 36:49 Why serving the community and being fiscally responsible should go hand in hand. 38:05 EP500 with Stacey.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, discusses #infusion #drugpricing on our #healthcarepodcast. #healthcare #podcast #financialhealth #commericalpayermarketplace #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Jacob Asher (Take Two: EP398), Stacey Richter (EP500), Dr Jay Kimmel, Mark Noel, Gary Campbell (Take Two: EP341), Zack Kanter, Mark Newman, Stacey Richter (INBW45)

RPH is BACK! Amy Bowers-Cordalis joins RPH Co-host Elena Ortiz to talk about her new book, the liberation of the Klamath River and her family's contributions to that struggle. This is a story of hope and triumph. Watch the video edition on The Red Nation Podcast YouTube channel Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon https://www.patreon.com/redmediapr

RPH co-host Melanie Yazzie continues our series of frontline reports from Minneapolis. In this episode, Melanie speaks to Rachel Thunder from the Indigenous Protector Movement and NDN's Lorenzo Serna. Watch the video edition on The Red Nation Podcast YouTube channel Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon https://www.patreon.com/redmediapr

Red Power Hour is back! The RPH crew discusses the fascist attack on Minneapolis by ICE and the mass mobilization against it. Joining co-hosts Melanie Yazzie and Elena Ortiz is TRN comrade Demetrius Johnson. Empower our work: GoFundMe: https://www.gofundme.com/f/empower-red-medias-indigenous-content  Subscribe to The Red Nation Newsletter: https://www.therednation.org/ Patreon https://www.patreon.com/redmediapr